ROSG: Message Board for Rosetta Genomics Ltd. | Forum profile

Wonder how much Berlin's decision to come to Rosetta had to do with the involvement of J&J in microRNA Dx.   MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer Mitch Raponi 1 ,  Lesley Dossey 2 ,  Tim Jatkoe 2 ,  Xiaoying Wu 1 ,  Guoan Chen 3 ,  Hongtao Fan 1  and  David G. Beer 3 1  Centocor Research and Development, Radnor,...

<<Just think how exciting it would be to get ROSG back to IPO levels. :) >> I'd settle for myPO levels msg 1740

Rosetta Genomics Strengthens MicroRNA Intellectual Property Position with Receipt of Additional Patent This is the third patent issued to Rosetta Genomics covering microRNAs The company has received notices of allowance for an additional eight patent applications related to human microRNAs REHOVOT, Israel & PHILADELPHIA--(BUSINESS WIRE)--Nov. 5, 2009-- Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular...

I think the battle between ffDNA and cell capture is one of who can get the cleanest genetic data (copy number variants, SNPs). Cell sorting and ffDNA sequencing (see Steve Quake PNAS paper) both seem to work, but both are still early and have challenges to sort though. And then there's Sequenom, using transcript levels and artificial data tinkering to detect trisomy 21.    Thing about this market is that first to the...

"Double Secret Probation"   http://www.youtube.com/watch?v=rnVKkJFYkhg msg 1735

it could be used in the context of an annual checkup; so that one blood draw will search for all sorts of mrnas, including pregnancies. in addition, this is probably just the beginning of a pregnancy test, and it will probably include screening for fetal diseases. (i don't know enuff about it say which diseases, but i vaguely know that there are fetal diseases). msg 1728

THIS I like-   "I am an entrepreneur at heart, and I look forward to honing and executing our growth strategy and communicating our plans to the investment community by the end of the year."  msg 1741

This seems like a good move. Mr. Berlin sounds like a guy with business acumen. That's what is needed right now; great science without business skills never produces a good return for investors. Great science and a strong leader could move ROSG back up.   I'm pleased to see this move. Just think how exciting it would be to get ROSG back to IPO levels. :)  msg 1739